Favipiravir for treating COVID-19

CONCLUSIONS: The low- to very low-certainty evidence means that we do not know whether favipiravir is efficacious in people with COVID-19 illness, irrespective of severity or admission status. Treatment with favipiravir may result in an overall increase in the incidence of adverse events but may not result in serious adverse events.PMID:38314855 | PMC:PMC10840071 | DOI:10.1002/14651858.CD015219.pub2

Source: Cochrane Database of Systematic Reviews - February 5, 2024 Category: General Medicine Authors: Pritish Korula Hanna Alexander Jisha Sara John Richard Kirubakaran Bhagteshwar Singh Prathap Tharyan Priscilla Rupali Source Type: research